Already registered for Bio€quity Europe?

Bio€quity Europe 2023

Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs – join the discussion in Dublin, or attend from home via a digital pass. Plus take advantage of two bonus days of digital 1x1 meetings. Additional details to be released shortly, check back for updates.

With 800+ confirmed delegates from 29 countries and 150+ Presenting Companies spanning over 23 countries, Bio€quity Europe 2022 was the largest event yet!

With 2022 being sold out, we have just opened registration for Bio€quity Europe 2023 in Dublin, Ireland.  Take advantage of the early bird pricing now to secure your spot.

Looking for Bio€quity Europe 2022?


Joshua Berlin
Head of Business Development
BioCentury Inc.
Karen Bernstein, Ph.D.
Co-Founder & Chairman
BioCentury Inc.
Simone Fishburn, Ph.D.
Vice President & Editor in Chief
BioCentury Inc.
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Eric Pierce
BioCentury Inc.


Sponsorship opportunities available for Bio€quity Europe 2023Speak with a BioCentury representative today

Interested in becoming a Presenting Company for the next Bio€quity Europe in Dublin?Apply now to be considered for the Bio€quity Europe Class of 2023


“Bio€quity Europe is a 'must go' for both VCs and CEOs of life science companies in Europe ... it is THE event where you can feel the pulse of the industry ...”

Antoine Papiernik
Chairman & Managing Partner
Sofinnova Partners

"Bio€quity is for me the most important investor conference for life science in Europe. If you want to know how the investor community ticks and want to meet the most important companies and rising future stars in Europe it´s the place to be." ​

Harald Poth, Ph.D.
Senior Investment Manager
LBBW Venture​

"If you are a VC or biotech CEO in Europe this is the conference to attend. Bio€quity is a great venue bringing the relevant players together. It’s not too big, not too small and it’s THE place to network." ​

Christina Takke, Ph.D.
Managing Partner
V-Bio Ventures​